HomeQuestion

Should orlistat be avoided in patients with a history of kidney stones?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you decide between bariatric surgery and a GLP-1 receptor agonist for patients with metabolic dysfunction-associated steatotic liver disease who have not met weight loss goals after six months of lifestyle interventions?

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

When treating fatty liver disease with resmetirom, how often should a FibroScan be repeated to assess treatment response?

Can procalcitonin be used as a marker for endothelial dysfunction emanating from chronic inflammation of obesity?

Do you recommend concurrent hormone replacement therapy in postmenopausal women on GLP1 R agonist therapy for weight loss given better cardiometabolic outcomes?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Should orlistat be avoided in patients with a history of kidney stones? | Mednet